- Home
- IMMX vs SPRU Comparison
IMMX vs SPRU Comparison
Compare IMMX & SPRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- SPRU
- Stock Information
- Founded
- IMMX 2014
- SPRU 2008
- Country
- IMMX United States
- SPRU United States
- Employees
- IMMX N/A
- SPRU N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- SPRU Auto Parts:O.E.M.
- Sector
- IMMX Health Care
- SPRU Consumer Discretionary
- Exchange
- IMMX Nasdaq
- SPRU Nasdaq
- Market Cap
- IMMX 50.1M
- SPRU 46.9M
- IPO Year
- IMMX 2021
- SPRU N/A
- Fundamental
- Price
- IMMX $1.75
- SPRU $2.37
- Analyst Decision
- IMMX Strong Buy
- SPRU
- Analyst Count
- IMMX 1
- SPRU 0
- Target Price
- IMMX $7.00
- SPRU N/A
- AVG Volume (30 Days)
- IMMX 47.5K
- SPRU 47.0K
- Earning Date
- IMMX 05-08-2025
- SPRU 03-31-2025
- Dividend Yield
- IMMX N/A
- SPRU N/A
- EPS Growth
- IMMX N/A
- SPRU N/A
- EPS
- IMMX N/A
- SPRU N/A
- Revenue
- IMMX N/A
- SPRU $77,582,000.00
- Revenue This Year
- IMMX N/A
- SPRU $1.54
- Revenue Next Year
- IMMX N/A
- SPRU $3.40
- P/E Ratio
- IMMX N/A
- SPRU N/A
- Revenue Growth
- IMMX N/A
- SPRU N/A
- 52 Week Low
- IMMX $1.26
- SPRU $2.17
- 52 Week High
- IMMX $3.13
- SPRU $4.89
- Technical
- Relative Strength Index (RSI)
- IMMX 41.38
- SPRU 43.19
- Support Level
- IMMX $1.64
- SPRU $2.41
- Resistance Level
- IMMX $1.90
- SPRU $2.92
- Average True Range (ATR)
- IMMX 0.14
- SPRU 0.26
- MACD
- IMMX 0.00
- SPRU -0.00
- Stochastic Oscillator
- IMMX 10.44
- SPRU 6.88
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is a leading owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to approximately 75,000 home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's primary customers are homeowners and the Company's core solar service offerings generate revenues primarily through (i) the sale of electricity generated by its home solar energy systems to homeowners, (ii) third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and (iii) the servicing of those agreements for other institutional owners of home solar energy systems.